Naoki Matsumoto
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 24
- Hepatitis C virus research 21
- Liver Disease and Transplantation 21
- Hepatitis Viruses Studies and Epidemiology 8
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 44
- Hepatitis B Virus Studies 13
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- Pancreatic and Hepatic Oncology Research 6
- Co-authors
- Mitsuhiko MoriyamaMasahiro OgawaTatsuo KandaShunichi MatsuokaKazushige NireiRyota MasuzakiReina SasakiHiroaki Yamagami
- Journals
- SHILAP Revista de lepidopterología (3 papers)Chemical Communications (1 paper)Journal of Virology (1 paper)
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Naoki Matsumoto
128 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 136
- Hepatology 431
- Epidemiology 507
- Cardiology and Cardiovascular Medicine 149
- Endocrinology, Diabetes and Metabolism 108
- Surgery 285
Countries citing papers authored by Naoki Matsumoto
This map shows the geographic impact of Naoki Matsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Matsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Matsumoto more than expected).
Fields of papers citing papers by Naoki Matsumoto
This network shows the impact of papers produced by Naoki Matsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Matsumoto. The network helps show where Naoki Matsumoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoki Matsumoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 3 | |
| 12 | [Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure]. | 2011 | 2 |
| 13 | 2008 | 0 | |
| 14 | 2007 | 2 | |
| 15 | 2007 | 3 | |
| 16 | 2007 | 7 | |
| 17 | 2007 | 5 | |
| 18 | New Holter Monitoring Analysis System : Synthesizing 12-Lead Electrocardiograms Using a Calculation of the Lead Vectors | 2004 | 2 |
| 19 | Homoclinic bifurcation of PLL with asymmetric triangular phase detector | 1996 | 0 |
| 20 | 1986 | 1 |
About Naoki Matsumoto
Naoki Matsumoto is a scholar working on Hepatology, Epidemiology and Surgery, having authored 145 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (44 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Hepatitis C virus research (21 papers), Liver Disease and Transplantation (21 papers), Hepatitis B Virus Studies (13 papers), Hepatitis Viruses Studies and Epidemiology (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Hepatology (431 citations), Epidemiology (507 citations) and Cardiology and Cardiovascular Medicine (149 citations). Naoki Matsumoto has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Mitsuhiko Moriyama, Masahiro Ogawa, Tatsuo Kanda, Shunichi Matsuoka, Kazushige Nirei, Ryota Masuzaki, Reina Sasaki, Hiroaki Yamagami, Kazumichi Kuroda and Mariko Fujisawa. Their work appears in journals such as SHILAP Revista de lepidopterología, Chemical Communications and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.